Showing 20 of 24 recruiting trials for “Myeloproliferative neoplasm”
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms
👨⚕️ Anna Halpern, MD, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Mar 2026View details ↗
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
👨⚕️ Rachel Salit, MD, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Feb 2026View details ↗
Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE)
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
👨⚕️ Anand A Patel, City of Hope Comprehensive Cancer Center LAO📍 25 sites📅 Started Aug 2025View details ↗
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
RecruitingNCT06480591 ↗
Evaluation of the Pathobiology of CALR-mutated MPN Cells
Long-term Efficacy of Once Daily Versus Twice Daily Aspirin in High-risk MPN Patients with Aspirin Resistance
RecruitingNCT06462664 ↗
Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)
I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients
RecruitingNCT06022328 ↗
Impact of Epigenetic Age on Clinic-biological Presentation and Prognosis in Myeloproliferative Neoplasms Epigenetic Age in Myeloproliferative Neoplasms (EpiC)
Study of Venetoclax and Azacitidine in Advanced BCR-ABL Negative Myeloproliferative Neoplasms
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
RecruitingNCT05839717 ↗
Determination of the Clonality Profile in Myeloproliferative Neoplasms and Association With the Thrombotic Complications (CLOJAK)
Cord Blood Transplant in Adults With Blood Cancers
👨⚕️ Ann Jakubowski, MD, Memorial Sloan Kettering Cancer Center📍 1 site📅 Started May 2023View details ↗
RecruitingNCT06715267 ↗
Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications (VYP)
RecruitingNCT05850273 ↗
Mechanism of Action of Interferon in the Treatment of Myeloproliferative Neoplasms
👨⚕️ Florence Pasquier, MD,PhD, florence.pasquier@gustaveroussy.fr📍 1 site📅 Started Mar 2023View details ↗
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
RecruitingNCT07410247 ↗
MPN Childhood Registry
👨⚕️ Axel Karow, MD, Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany📍 1 site📅 Started Jan 2023View details ↗
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →